Focal segmental glomerulosclerosis and hepatitis C virus: A case report

Panminerva Medica

Volumn 43, Issue 1, 2001, Pages 49-52

  Motta, M ^a   Malaguarnera, M ^a,b   Restuccia, N ^a   Romano, M ^a   Vinci, E ^a   Pistone, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Glomerulosclerosis, focal; Hepatitis C; Interferon alpha, therapeutic use

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEPATITIS C; HUMAN; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA;

EID: 0035294091     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Velosa JA, Donadio JV, Holley KE. Focal sclerosing glomerulopathy. A clinicopathologic study. Mayo Clin Proc 1975;50:121-33.
2. Beaufils H, Alphonse JC, Guedon J, Legrain M. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nefron 1978;21:75-85.
3. Schoeneman MJ, Bennet B, Greifer J. The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 1978;9:45-54.
4. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 1978;10:213-8.
5. Korbet SM, Schwartz MM, Lewis EJ. The prognosis of focal segmental glomerulosclerosis of adulthood. Medicine 1986;66:304-11.
6. Mallick NP. Epidemiology and natural course of idiopathic nephrotic syndrome. Clin Nephrol 1991;35:S-3.
7. Lopes GS, Marques LP, Rioja LS, Basilio de Oliveira CA, Oliveira AV, Nery AC et al. Glomerular disease and human immunodeficiency virus infection in Brasil. Am J Nepbrol 1992;12:281-7.
8. Kopp JB, Klotman ME, Adler SH, Bruggeman LA. Dickie P, Marinos NJ et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 1992;89:1577-81.
9. Buyukbabani N, Durrbach A, Chauveau D, Trawale JM, Viard JP, Diouf B et al. Nephropathies et infection par le virus VIH 1. Etude anatomo-clinique. Nephrologie 1993;14:143-9.
10. Bodi I, Abraham AA, Kimmel PL. Macrophages in human immunodeficiency virus-associated kidney diseases. Am J Kidney Dis 1994;24:7627-7.
11. Smith MC, Pawar R, Carey JT, Graham RC, Jacobs GH. Menon A et al. Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy. Am J Med 1994;97:145-51.
12. Singhal PC, Sharma P, Garg P. HIV-1 gp 160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. Am J Pathol 1995;147:1780-9.
13. Connolly JO, Weston CE, Hendry BM. HIV-associated renal disease in London hospitals. Q J Med 1995;88:627-34.
14. Romosan I, Voiculescu M. Reflux nephropathy in adults. Rom J Intern Med 1992;30:231-41.
15. Becker GJ, Kincaid Smith P. Reflux nephropathy: the glomerular lesion and progression of renal failure. Pediatr Nephrol 1993;7:365-9.
16. Hinchliffe SA, Kreczy A, Ciftci AO, Chan YF, Judd BA, van Velzen D. Focal and segmental glomerulosclerosis in children with reflux nephropathy. Pediatr Pathol 1994;14:327-38.
17. Orikasa S, Fukuzaki A, Konda R. Obstructive and reflux nephropathy. Nippon Rinsho 1995;53:2019-26.
18. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
19. Misiani R, Bellavita P, Fenili D. Hepatitis C virus and cryoglobulinemia. N Engl J Med 1993;328:1121.
20. Pasquariello A, Ferri C, Moriconi L, La Civita L, Longobardo G, Lombardini F et al. Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus. Am J Nephrol 1993;13:300-4.
21. Doutrelepont JM, Adler M, Willelms M, Durez P, Yap SK. Hepatitis C virus infection and membranoproliferative glomerulonephritis. Lancet 1993;341:317.
22. Harlé JR, Disdier P, Dussol B, Bolla G, Casanova P, Weiller PJ. Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 1993;341:904.
23. Albarracin C, Gomez Campdera FJ, Lopez Gomez JM, Perez Garcia R, Lago M, Valderrabano F. Membranoproliferative glomerulonephritis and hepatitis C virus infection. Nephron 1994;67:250.
24. Cacoub C, Lunel-Fabiani F, Musset L, Perrin M, Frangeul L, Léger JM et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
25. Cacoub P, Lunel-Fabiani F, Huong Du LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-6.
26. Deny P, Bonacorsi S, Guillevin L, Quint L. Association between hepatitis C virus and polyarteritis nodosa. Clin Exp Rheumatol 1992;10: 319-24.
27. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-9
28. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991;59:319-20.
29. Davda R, Peterson J, Weiner R, Croker B, Lau JY. Membranous glomerulonephritis in association with hepatitis C virus. Am J Kidney Dis 1993;22:452-5.
30. Horikoshi S, Okada T, Shirato I, Inokuchi S, Ohmuro H, Tomino Y et al. Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis. Nephron 1993;64:462-4.
31. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoprolipherative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-9.
32. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M et al. Hepatitis C virus infection and membranoprolipherative glomerulonephritis in Japan. J Am Soc Nephrol 1995;6:220-3.
33. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-8.
34. Malaguarnera M, Restuccia N, Laurino A, Giugno I, Trovato BA, Motta M. Maladies immunologiques et virus de l'hépatite C. Rev Med Interne 1996;17:305-12.
35. Altraif IH, Abdulla AS, al Sebayel MI, Said RA, al Suhaibani MO, Jones AA. Hepatitis C associated glomerulonephritis. Am J Nephrol 1995;15:407-10.
36. Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996;28:752-8.
37. Hulton SA, Shah V, Byrne MR, Morgan G, Barrat TM, Dillon MJ. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 1994;8:135-9.
38. Dal Canton A, Fuiano G, Sepe V, Caglioti A, Ferrone S. Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney Int 1992;41:951-5.
39. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993;21:251-9.
40. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-4.
41. Ozawa T, Levisohn P, Orsini E, McIntosh RM. Acute immune complex disease associated with hepatitis: etiopathogenic and immunopathologic studies of the renal lesion. Arch Pathol Lab Med 1976;100:484-6.
42. Levy M, Kleinknecht C. Membranous glomerulonephritis and hepatitis B virus infection. Nephron 1980;26:259-65.
43. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663-76.
44. Nakopoulou L, Stefanaki K, Zeis PM, Boletis J, Papadakis J, Vosnides G et al. The frequency of hepatitis B virus infection in Greek patients with various types of glomerulonephritis. Eur J Epidemiol 1994;10:737-42.
45. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P et al. Membranoprolipherative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
46. Lunel F, Musset L, Franjeul L, Cacoub P, Manns M, Perrin M et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
47. Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Replication of hepatitis C virus in peripheral blood mononuclear cells: effect of alpha-interferon therapy. J Hepatol 1992;16:380-3.
48. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extra-hepatic HCV RNA strands in chronic hepatitis C: different pattern of response to interferon treatment. Hepatology 1993;18:1050-4.
49. Saleh MG, Tibbs CJ, Pereira LMMB, Bomford AB, McFarlane IG, Williams R. HCV-RNA in peripheral blood mononuclear cells (PBMC) but not in liver: evidence for extrahepatic HCV replication in the absence of hepatic replication. Hepatology 1993;18:81A (Abstract).
50. Töx U, Kolbe E, Tien D, Kräublich HG, Hofmann WJ, Müller HM et al. Detection of hepatitis C virus RNA in liver paraffin sections by in situ hybridisation: distribution and identification of infected cells. Hepatology 1993;18:82A (Abstract).
51. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patient with mixed cryoglobulinemia. Hepatology 1995;21:305-12.
52. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor a gene 2 expression and response to interferon in chronic hepatitis C. Hepatology 1996;23:210-7.
53. Misiani R, Marchesi D. Virus dell'epatite C e glomerulonefriti. Il Fegato 1994;2:17-23.
54. Rodriguez-Iturbe B. Epidemic poststreptococcal glomerulonephritis. Kidney Int 1984;25:129-36.
55. Durand JM, Kaplanski G, Lefevre P, Richard MA, Andrac L, Trepo C et al. Effect of interferon-α2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis 1992;165:778-9.
56. Knox TA, Hillyer CD, Kaplan MM, Berkman EM. Mixed cryoglobulinemia responsive to interferon-α. Am J Med 1991;91:554-5.
57. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.